Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Practice

Highlights of the National Advisory Committee on Immunization statement on influenza for the 2006–2007 season

Joanne M. Langley
CMAJ September 26, 2006 175 (7) 742; DOI: https://doi.org/10.1503/cmaj.060964
Joanne M. Langley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Although international avian influenza may be occupying media headlines and the minds of many Canadians, behind-the-scenes planning by the public health community and health care providers is underway for this year's seasonal visit of influenza. In the National Advisory Committee on Immunization (NACI) annual statement on influenza immunization,1 published June 15, are found a few changes that affect our strategies for prevention in 2006–2007.

NACI has reiterated the importance of vaccine as the primary means to prevent influenza, which is a major cause of ambulatory visits, antimicrobial use, hospitalization and death, particularly among those older than 65. In Canada the national strategy to decrease the burden of illness attributable to influenza has been risk-based, rather than universal, immunization. The programs to identify and deliver vaccine to subpopulations at higher risk than healthy people for complications are provincial– territorial. In much of Canada, physicians must identify the individuals in their practices who are at risk, educate them and their families about vaccine, and deliver 1 or 2 doses to each as needed, all within a few months every fall.

The groups recommended to receive influenza vaccine in 2006–2007 have not changed, although a new combined category for those at high risk has been created, inclusive of people in higher-risk age groups (5–23 months or > 65 years) or who have an underlying health condition. Populations that were added last year to the list of recommended recipients (i.e., healthy children aged 6–23 months, their caregivers, and people with conditions that “compromise the management of respiratory secretions and are associated with an increased risk of aspiration”)2 continue to be recognized as being at increased risk of infection.

NACI continues to strongly recommend vaccine for persons who can transmit influenza to high-risk people and has worded this recommendation more inclusively. All household contacts of individuals at high risk should be vaccinated, as should all providers of health or other care in facility or community settings “who, through their activities, are potentially capable of transmitting influenza to vulnerable populations.”

This year's statement emphasizes the importance of immunizing pregnant women who have underlying health conditions and briefly reviews the supporting literature. Although vaccination is encouraged in any trimester of pregnancy, NACI has not taken the step (as has been done in the United States)3 of recommending vaccine for healthy pregnant women (unless they are expected to deliver during flu season, since they then become a contact of the infant).

For the rest of the Canadian population, healthy people aged 2–64 years who are not pregnant and will not be in close contact at home or at work with high-risk people, NACI continues to encourage vaccine. This permissive wording allows physicians to recommend vaccine for all their patients, although at present only Ontario and the Yukon fund such programs. The evidence of influenza vaccine efficacy is strongest in healthy people, among whom cases are reduced by up to 70%.4 In the universal influenza immunization program in Ontario, increasing influenza vaccine coverage of those aged ≥ 12 years has been associated with higher coverage for people with high-risk chronic conditions than has occurred in other provinces.5 This suggests that universal immunization may increase vaccine delivery to high-risk groups. The merits of a universal approach to influenza vaccination were discussed recently at the US Advisory Committee on Immunization Practices (ACIP), along with a proposal to work toward immunizing all school-aged children by 2008– 2009 and universal immunization of Americans by 2012–2013. This year, ACIP voted to expand immunization of young children to include those aged up to 58 months.3 Since immunization of people 50 years or older is already recommended, this can be seen as an incremental step toward universal immunization.

The other notable recommendation that will affect planning for the coming season is NACI's advice to use only neuraminidase inhibitors for antiviral prophylaxis. This recommendation was made in the midst of last year's influenza season, when antiviral susceptibility testing revealed that 82% of isolates were resistant to amantadine, and that these drug-resistant viruses were present across Canada.6 The advice to use only neuraminidase inhibitors will most affect physicians who work in institutions where outbreaks occur (including residential settings) or who provide care to high-risk people who cannot be given vaccine or are immunocompromised. It is unclear whether amantadine will have a role in the treatment or prevention of influenza in seasons to come.

Footnotes

  • This article has been peer reviewed.

REFERENCES

  1. 1.↵
    National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2006–2007 season. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2006;32(ACS-7):1-27.
    OpenUrlPubMed
  2. 2.↵
    NACI. Statement on influenza vaccination for the 2005– 2006 season. Can Commun Dis Rep 2005;31(ACS-6):1-30.
    OpenUrlPubMed
  3. 3.↵
    Smith, NM, Bresee JS, Shay DK, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55(RR-10):1-42.
    OpenUrlPubMed
  4. 4.↵
    Langley JM, Faughnan ME. Prevention of influenza in the general population [review]. CMAJ 2004;171(10):1213-22.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    Kwong JC, Sambell C, Johansen H, et al. The effect of universal influenza immunization on vaccination rates in Ontario. Health Rep 2006;17:31-40.
    OpenUrlPubMed
  6. 6.↵
    NACI. Update on influenza vaccination for the 2005– 2006 season. Can Commun Dis Rep 2006;32(ACS-2):1-3.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 175 (7)
CMAJ
Vol. 175, Issue 7
26 Sep 2006
  • Table of Contents
  • Index by author

Article tools

Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Highlights of the National Advisory Committee on Immunization statement on influenza for the 2006–2007 season
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Highlights of the National Advisory Committee on Immunization statement on influenza for the 2006–2007 season
Joanne M. Langley
CMAJ Sep 2006, 175 (7) 742; DOI: 10.1503/cmaj.060964

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Highlights of the National Advisory Committee on Immunization statement on influenza for the 2006–2007 season
Joanne M. Langley
CMAJ Sep 2006, 175 (7) 742; DOI: 10.1503/cmaj.060964
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Modern Rhesus (Rh) typing in transfusion and pregnancy
  • Remdesivir for patients with COVID-19
  • Syphilis presenting with moth-eaten alopecia
Show more Practice

Similar Articles

Collections

  • Topics
    • Vaccination
    • Infectious diseases
    • Family medicine, general practice, primary care

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire